跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EBIXA memantine hydrochloride 20mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
EBIXA memantine hydrochloride 20mg film-coated tablet blister pack
Approved
STANDARD
EBIXA memantine hydrochloride 20mg film-coated tablet blister pack
Lundbeck Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
bf8ab63d11c9f33b
Company
Lundbeck Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
bf8ab63d11c9f33b
Product Name
EBIXA memantine hydrochloride 20mg film-coated tablet blister pack
Artg Id
156299
Artg Name
EBIXA memantine hydrochloride 20mg film-coated tablet blister pack
Sponsor
Lundbeck Australia Pty Ltd
Company Detail Path
/organization/lundbeck-australia-pty-ltd
Artg Date
2009-09-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/1fcfe4f526d1d7e58aedb26f6302e03d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/0a723d0e209ca187861b6e2aa69b2134.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
bf8ab63d11c9f33b
Type
Standard
Back to TGA Approvals